Peripheral neuropathy is a debilitating side effect of the increasingly utilized PD-1 inhibitors, and our findings underscore the importance of increased awareness and standardized screening practices for immunotherapy-associated neuropathy. This evidence concerns the gene PDCD1 and neuropathy.